Arrhythmogenic right ventricular dysplasia 9
MONDO:0012180Any familial isolated arrhythmogenic right ventricular dysplasia in which the cause of the disease is a mutation in the PKP2 gene.
Also known as: ARVC9, ARVD9, PKP2 familial isolated arrhythmogenic right ventricular dysplasia, arrhythmogenic right ventricular cardiomyopathy 9, arrhythmogenic right ventricular dysplasia 9, arrhythmogenic right ventricular dysplasia type 9, arrhythmogenic right ventricular dysplasia, familial, type 9, familial isolated arrhythmogenic right ventricular dysplasia caused by mutation in PKP2
14 clinical trials for this condition and its sub-types, 5 tagged with Arrhythmogenic right ventricular dysplasia 9 itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
One-Time gene infusion aims to fix inherited heart disease
Disease control Recruiting nowThis early-stage trial tests a single intravenous dose of a gene therapy called RP-A601 in 9 adults with a genetic heart condition (PKP2-ACM) that causes dangerous heart rhythms and heart failure. The therapy delivers a working copy of the PKP2 gene to heart cells to restore prot…
Phase 1 • Sponsor: Rocket Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Researchers to track rare heart disease in 36 patients
Knowledge-focused Recruiting nowThis study aims to describe how a genetic heart condition called PKP2-ACM naturally progresses over time in people who receive standard care. Researchers will monitor heart rhythm, biomarkers, and quality of life in 36 participants aged 12 and older. The goal is to better underst…
Sponsor: Rocket Pharmaceuticals Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC